牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

康华生物（300841）

5.0

综合诊断：5.0分打败了28%的股票！

卖出
减持
中性
增持
买入

短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
中期趋势：
下跌有所减缓，仍应保持谨慎。
长期趋势：
已有79家主力机构披露2025-12-31报告期持股数据，持仓量总计483.84万股，占流通A股4.07%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

5.8分

3.5分

5.2分

2.8分

6.1分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：5.8技术面打败了43%的股票技术面评分前10的股票

近期的平均成本为59.29元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

技术面得分最高的股票

平均成本

近期的平均成本为59.29元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"59.29","date":1776327562,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势跑输大盘，跑赢行业平均水平。

[{"date":"2026.04.17","stock":"0.81","trade":"-1.25","ind":"0.60"},{"date":"2026.04.16","stock":"-0.99","trade":"0.56","ind":"2.05"},{"date":"2026.04.15","stock":"-2.13","trade":"1.39","ind":"-0.97"},{"date":"2026.04.14","stock":"4.39","trade":"1.04","ind":"1.61"},{"date":"2026.04.13","stock":"2.72","trade":"0.23","ind":"0.69"},{"date":"2026.04.10","stock":"0.96","trade":"1.34","ind":"2.24"},{"date":"2026.04.09","stock":"-3.10","trade":"-1.48","ind":"-0.33"},{"date":"2026.04.08","stock":"2.75","trade":"1.96","ind":"4.79"},{"date":"2026.04.07","stock":"1.34","trade":"0.21","ind":"0.36"},{"date":"2026.04.03","stock":"-4.13","trade":"-2.48","ind":"-0.99"},{"date":"2026.04.02","stock":"0.90","trade":"0.58","ind":"-1.60"},{"date":"2026.04.01","stock":"1.79","trade":"4.76","ind":"1.70"},{"date":"2026.03.31","stock":"0.19","trade":"-0.80","ind":"-1.81"},{"date":"2026.03.30","stock":"0.37","trade":"0.87","ind":"-0.25"},{"date":"2026.03.27","stock":"4.30","trade":"3.53","ind":"1.13"},{"date":"2026.03.26","stock":"-1.81","trade":"-0.83","ind":"-1.41"},{"date":"2026.03.25","stock":"1.28","trade":"0.43","ind":"1.95"},{"date":"2026.03.24","stock":"2.44","trade":"3.52","ind":"1.43"},{"date":"2026.03.23","stock":"-9.01","trade":"-5.93","ind":"-3.76"},{"date":"2026.03.20","stock":"-2.03","trade":"-1.88","ind":"-0.25"},{"date":"2026.03.19","stock":"-1.84","trade":"-2.16","ind":"-2.02"}]

康华生物,深证成指,生物制品指数

压力支撑

该股压力位为59.10元，支撑位为58.38元。

[{"text":"\u538b\u529b\u4f4d","value":"59.10","date":1776355200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"58.38","date":1776355200,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.5资金面打败了32%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力筹码较分散，呈低度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金总体无进出。

更新时间：04月17日 20:31

机构今日流向(万元)	-1886.49	机构5日流向(万元)	-1003.42
机构10日流向(万元)	-5049.46	机构20日流向(万元)	-4655.06

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少3961.24万股，其中基金净减仓9家，主力净增仓18家，暂未发现中长期投资价值。

截止2025-12-31，共79家主力机构（基金79家），持仓量总计483.84万股，占流通A股4.07%
其中，基金持仓与2025-06-30相比：
增仓：8家，增持 5.85万股
减仓：17家，减持 14.77万股
新出现在主力名单中：51家，持有265.91万股
从主力名单中消失：33家，原持有4218.23万股

消息面诊股

诊断结果：5.2消息面打败了38%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	临时股东大会	2026-04-11
一般消息	募资投向	公司购买资产	2026-04-11
一般消息	重大事项	关联交易	2026-04-11
一般消息	高管变动	个人原因	2026-01-28
重大利空	业绩预告	业绩大幅下降	2026-01-24
一般消息	重大事项	公司股东股份解押	2025-12-01
一般消息	高管变动	因工作调整原因	2025-11-25
一般消息	资产重组	公司股权转让	2025-11-07
一般消息	分红转增	不分配不转增	2025-08-26
一般消息	重大事项	公司股东股份解押	2025-07-03
一般消息	重大事项	公司股东股份解押	2025-07-01
利好	分红转增	10派10元(含税)	2025-04-19

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	1条	1条	0条

行业面诊股

诊断结果：2.8行业面打败了22%的股票生物制品行业最新资金流向

近10日来该行业走势不明显，跑输大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑输大盘。

[{"date":"2026.04.17","price":"0.60","value":"-1.25"},{"date":"2026.04.16","price":"2.05","value":"0.56"},{"date":"2026.04.15","price":"-0.97","value":"1.39"},{"date":"2026.04.14","price":"1.61","value":"1.04"},{"date":"2026.04.13","price":"0.69","value":"0.23"},{"date":"2026.04.10","price":"2.24","value":"1.34"},{"date":"2026.04.09","price":"-0.33","value":"-1.48"},{"date":"2026.04.08","price":"4.79","value":"1.96"},{"date":"2026.04.07","price":"0.36","value":"0.21"},{"date":"2026.04.03","price":"-0.99","value":"-2.48"},{"date":"2026.04.02","price":"-1.60","value":"0.58"},{"date":"2026.04.01","price":"1.70","value":"4.76"},{"date":"2026.03.31","price":"-1.81","value":"-0.80"},{"date":"2026.03.30","price":"-0.25","value":"0.87"},{"date":"2026.03.27","price":"1.13","value":"3.53"},{"date":"2026.03.26","price":"-1.41","value":"-0.83"},{"date":"2026.03.25","price":"1.95","value":"0.43"},{"date":"2026.03.24","price":"1.43","value":"3.52"},{"date":"2026.03.23","price":"-3.76","value":"-5.93"},{"date":"2026.03.20","price":"-0.25","value":"-1.88"},{"date":"2026.03.19","price":"-2.02","value":"-2.16"}]

深证成指,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	赛伦生物	52.42%	15.55%	6.0分
2	君实生物	35.17%	18.28%	6.3分
3	诺诚健华	27.91%	6.61%	5.9分
4	三生国健	26.28%	4.33%	6.0分
5	近岸蛋白	23.26%	14.63%	5.8分
6	荣昌生物	23.21%	10.80%	6.1分
7	-	22.18%	-2.75%	分
8	艾迪药业	20.55%	4.76%	5.5分
9	智翔金泰	18.01%	4.04%	5.5分
10	科兴制药	17.78%	3.46%	5.3分
11	通化东宝	16.00%	1.91%	5.3分
12	昊帆生物	14.50%	5.63%	6.1分
13	迈威生物	14.47%	2.27%	4.8分
14	百普赛斯	13.78%	-1.66%	4.8分
15	神州细胞	12.45%	5.61%	5.1分
16	赛升药业	9.65%	4.19%	5.0分
17	甘李药业	6.37%	1.61%	5.5分
18	-	6.03%	2.71%	分
19	义翘神州	5.53%	1.98%	5.4分
20	*ST双成	5.07%	6.38%	6.5分
21	我武生物	4.86%	2.02%	4.8分
22	凯因科技	4.79%	-0.56%	4.8分
23	安科生物	4.44%	0.30%	5.3分
24	康辰药业	3.85%	2.36%	5.8分
25	华兰疫苗	3.70%	0.25%	5.6分
26	万泽股份	3.62%	-4.84%	6.0分
27	百奥泰	1.68%	-0.17%	5.0分
28	沃森生物	0.56%	-0.80%	4.3分
29	华兰生物	0.53%	0.87%	5.6分
30	康华生物	0.08%	4.75%	5.0分
31	康希诺	-0.04%	7.37%	5.3分
32	康弘药业	-0.11%	-5.10%	4.5分
33	*ST四环	-0.33%	2.71%	5.7分
34	康泰生物	-0.71%	-0.78%	4.2分
35	金迪克	-1.01%	0.57%	4.4分
36	辽宁成大	-1.10%	-1.19%	5.7分
37	ST未名	-1.29%	3.52%	4.4分
38	西藏药业	-2.33%	-0.88%	4.9分
39	成大生物	-2.60%	-1.02%	4.4分
40	长春高新	-2.64%	0.72%	3.9分
41	-	-2.68%	-1.11%	分
42	智飞生物	-2.70%	-1.65%	4.6分
43	天坛生物	-4.11%	1.88%	5.0分
44	欧林生物	-4.56%	0.76%	5.1分
45	特宝生物	-4.64%	0.03%	4.9分
46	百克生物	-5.22%	-1.89%	4.2分
47	诺唯赞	-5.23%	-5.79%	4.3分
48	禾元生物	-5.40%	0.21%	4.2分
49	博雅生物	-5.80%	-0.05%	4.8分
50	卫光生物	-5.82%	0.48%	5.4分
51	派林生物	-6.65%	0.70%	5.0分
52	上海莱士	-6.86%	-0.70%	5.2分
53	博晖创新	-6.86%	-3.72%	4.3分
54	东宝生物	-7.34%	-3.46%	4.6分
55	优宁维	-10.18%	-0.46%	5.1分

<上一页 1 2 3 4 5...10 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：6.1基本面打败了63%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：强（100分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：很强，居行业前列，两项指标的行业排名分别为 16/71 ， 8/71。

[{"date":"2025-09-30","value":"5.44","vol":"-9.78"},{"date":"2025-06-30","value":"3.33","vol":"-0.61"},{"date":"2025-03-31","value":"0.60","vol":"0.46"},{"date":"2024-12-31","value":"11.45","vol":"-0.68"},{"date":"2024-09-30","value":"11.65","vol":"1.34"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	5.44	3.33	0.60	11.45	11.65
行业(%)	-9.78	-0.61	0.46	-0.68	1.34

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"92.29","vol":"67.61"},{"date":"2025-06-30","value":"92.78","vol":"68.28"},{"date":"2025-03-31","value":"94.43","vol":"68.43"},{"date":"2024-12-31","value":"94.20","vol":"69.85"},{"date":"2024-09-30","value":"94.27","vol":"70.47"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	92.29	92.78	94.43	94.20	94.27
行业(%)	67.61	68.28	68.43	69.85	70.47

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 48/71 ， 41/71。

[{"date":"2025-09-30","value":"-20.78","vol":"45.25"},{"date":"2025-06-30","value":"-34.70","vol":"6902.04"},{"date":"2025-03-31","value":"-55.70","vol":"6125.27"},{"date":"2024-12-31","value":"-9.23","vol":"47.35"},{"date":"2024-09-30","value":"7.10","vol":"175.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	-20.78	-34.70	-55.70	-9.23	7.10
行业(%)	45.25	6902.04	6125.27	47.35	175.00

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"-53.41","vol":"44.80"},{"date":"2025-06-30","value":"-62.64","vol":"5.44"},{"date":"2025-03-31","value":"-86.14","vol":"-8.46"},{"date":"2024-12-31","value":"-21.71","vol":"-9.81"},{"date":"2024-09-30","value":"10.02","vol":"-52.40"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	-53.41	-62.64	-86.14	-21.71	10.02
行业(%)	44.80	5.44	-8.46	-9.81	-52.40

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，两项指标的行业排名分别为 23/71 ， 44/71。

[{"date":"2025-09-30","value":"0.21","vol":"0.22"},{"date":"2025-06-30","value":"0.12","vol":"0.14"},{"date":"2025-03-31","value":"0.03","vol":"0.06"},{"date":"2024-12-31","value":"0.35","vol":"0.29"},{"date":"2024-09-30","value":"0.26","vol":"0.22"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.21	0.12	0.03	0.35	0.26
行业(次)	0.22	0.14	0.06	0.29	0.22

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.40","vol":"0.92"},{"date":"2025-06-30","value":"0.20","vol":"0.56"},{"date":"2025-03-31","value":"0.04","vol":"0.26"},{"date":"2024-12-31","value":"0.47","vol":"1.17"},{"date":"2024-09-30","value":"0.34","vol":"0.86"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	0.40	0.20	0.04	0.47	0.34
行业(次)	0.92	0.56	0.26	1.17	0.86

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"24.82","vol":"1.84"},{"date":"2025-06-30","value":"23.70","vol":"-1377.61"},{"date":"2025-03-31","value":"-12.10","vol":"-46.99"},{"date":"2024-12-31","value":"85.95","vol":"-11.33"},{"date":"2024-09-30","value":"24.16","vol":"-30.88"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	24.82	23.70	-12.10	85.95	24.16
行业	1.84	-1377.61	-46.99	-11.33	-30.88

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.80","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.93","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	0.80	-	1.93	-
行业	0.00	1.59	0.00	2.01	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 38/71 ， 40/71。

[{"date":"2025-09-30","value":"5.85","vol":"6.00"},{"date":"2025-06-30","value":"5.85","vol":"6.64"},{"date":"2025-03-31","value":"5.80","vol":"7.75"},{"date":"2024-12-31","value":"4.39","vol":"6.72"},{"date":"2024-09-30","value":"4.86","vol":"7.02"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	5.85	5.85	5.80	4.39	4.86
行业	6.00	6.64	7.75	6.72	7.02

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"5.47","vol":"4.84"},{"date":"2025-06-30","value":"5.38","vol":"5.30"},{"date":"2025-03-31","value":"5.28","vol":"6.35"},{"date":"2024-12-31","value":"4.06","vol":"5.40"},{"date":"2024-09-30","value":"4.46","vol":"5.66"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	5.47	5.38	5.28	4.06	4.46
行业	4.84	5.30	6.35	5.40	5.66

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 38/71 ， 39/71。

[{"date":"2025-09-30","value":"10.94","vol":"28.18"},{"date":"2025-06-30","value":"10.55","vol":"26.73"},{"date":"2025-03-31","value":"10.70","vol":"26.03"},{"date":"2024-12-31","value":"14.40","vol":"25.81"},{"date":"2024-09-30","value":"12.55","vol":"24.44"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	10.94	10.55	10.70	14.40	12.55
行业(%)	28.18	26.73	26.03	25.81	24.44

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.12","vol":"0.58"},{"date":"2025-06-30","value":"0.12","vol":"1.11"},{"date":"2025-03-31","value":"0.12","vol":"0.78"},{"date":"2024-12-31","value":"0.17","vol":"0.87"},{"date":"2024-09-30","value":"0.14","vol":"0.40"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.12	0.12	0.12	0.17	0.14
行业(%)	0.58	1.11	0.78	0.87	0.40

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
方正证券	2026-02-02	增持
中信建投证券	2026-01-29	买入

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"8.29","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"5.98","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"5.09","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"3.99","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"2.14","blueLineValue":"1.65","type":"YC"}]

[康华生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]